NM_005188.4:c.122_127delACCACC

Variant summary

Our verdict is Uncertain significance.
+2 Uncertain · Warm
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 2 classification points (ACGS-UK Somatic Oncogenicity v2025). O9_Moderate

The NM_005188.4(CBL):c.122_127delACCACC (p.His41_His42del) variant causes a disruptive inframe deletion change. The variant results in an in-frame change. The gene CBL is a tumor suppressor gene (CancerMine: 6 TSG, 61 oncogene, 11 driver citations). The gene CBL is a known oncogene (CancerMine: 6 TSG, 61 oncogene, 11 driver citations). The gene CBL is a cancer driver gene (CancerMine: 6 TSG, 61 oncogene, 11 driver citations). Note: allele frequency estimates from gnomAD may be inaccurate for this variant type (MNP or indel longer than 3 bp) due to technology limitations. The variant allele was found at a cumulative frequency of 0.0000173 (AC=27) in the gnomAD database across 1,556,370 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000503. Variant has been reported in ClinVar as Uncertain Significance (★★).

Frequency

Genomes: 𝑓 0.000099 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000085 ( 0 hom. )

Consequence

CBL
NM_005188.4 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 4.30

Publications

4 publications found
Variant links:
Genes affected
CBL (HGNC:1541): (Cbl proto-oncogene) This gene is a proto-oncogene that encodes a RING finger E3 ubiquitin ligase. The encoded protein is one of the enzymes required for targeting substrates for degradation by the proteasome. This protein mediates the transfer of ubiquitin from ubiquitin conjugating enzymes (E2) to specific substrates. This protein also contains an N-terminal phosphotyrosine binding domain that allows it to interact with numerous tyrosine-phosphorylated substrates and target them for proteasome degradation. As such it functions as a negative regulator of many signal transduction pathways. This gene has been found to be mutated or translocated in many cancers including acute myeloid leukaemia, and expansion of CGG repeats in the 5' UTR has been associated with Jacobsen syndrome. Mutations in this gene are also the cause of Noonan syndrome-like disorder. [provided by RefSeq, Jul 2016]
CBL Gene-Disease associations (from GenCC):
  • CBL-related disorder
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • juvenile myelomonocytic leukemia
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Noonan syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_005188.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 2 points.

O9Protein length change in non-repeat region
In-frame indel in non-repetitive region of known cancer gene (O9 moderate); In-frame indel in non-repetitive region — gene: oncogene/TSG

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_005188.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

CBL NM_005188.4
MANE Select
HGVSc / HGVSpc.122_127delACCACCp.His41_His42del
Exon rankExon 1 of 16
disruptive_inframe_deletion
Prot: NP_005179.2

Ensembl Transcripts

CBL ENST00000264033.6
TSL:1MANE Select
HGVSc / HGVSpc.122_127delACCACCp.His41_His42del
Exon rankExon 1 of 16
disruptive_inframe_deletion
Prot: ENSP00000264033.3UniProt: P22681
CBL ENST00000634586.1
TSL:5
HGVSc / HGVSpc.122_127delACCACCp.His41_His42del
Exon rankExon 1 of 18
disruptive_inframe_deletion
Prot: ENSP00000489218.1UniProt: A0A0U1RQX8
CBL ENST00000637974.1
TSL:5
HGVSc / HGVSpc.116_121delACCACCp.His39_His40del
Exon rankExon 1 of 17
disruptive_inframe_deletion
Prot: ENSP00000490763.1UniProt: A0A1B0GW38

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.0000988
AC:15
Hom:0
AN:151854
Cov:32
GnomAD2 exomes
AF: 0.0000461
AC:7
AN:151840
GnomAD4 exome
AF: 0.00000854
AC:12
Hom:0
AN:1404516
GnomAD4 genome
AF: 0.0000988
AC:15
Hom:0
AN:151854
Cov:32
TOPMed (Bravo)
AF: 0.0000718
AC:19
Hom:0
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.00
AC:0
Hom:0
AN:33382
Showing 6 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
SCHEMA
(Schizophrenia)
0.0000440 122704 0.00 029178
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not specified (1)
-
1
-
RASopathy (1)

Computational Scores

Mutation Taster
N/A125/75polymorphism
PhyloP100
Uncertain4.3
Showing 2 of 2 scores

Splicing Scores

No splicing scores have been computed for this variant.

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.